Obesity-related hypertension: possible pathophysiological mechanisms
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Hypertension is one of the major risk factors of cardiovascular diseases, but despite a century of clinical and basic research, the discrete etiology of this disease is still not fully understood. The same is true for obesity, which is recognized as a major global epidemic health problem nowadays. Obesity is associated with an increasing prevalence of the metabolic syndrome, a cluster of risk factors including hypertension, abdominal obesity, dyslipidemia, and hyperglycemia. Epidemiological studies have shown that excess weight gain predicts future development of hypertension, and the relationship between BMI and blood pressure (BP) appears to be almost linear in different populations. There is no doubt that obesity-related hypertension is a multifactorial and polygenic trait, and multiple potential pathogenetic mechanisms probably contribute to the development of higher BP in obese humans. These include hyperinsulinemia, activation of the renin–angiotensin–aldosterone system, sympathetic nervous system stimulation, abnormal levels of certain adipokines such as leptin, or cytokines acting at the vascular endothelial level. Moreover, some genetic and epigenetic mechanisms are also in play. Although the full manifestation of both hypertension and obesity occurs predominantly in adulthood, their roots can be traced back to early ontogeny. The detailed knowledge of alterations occurring in the organism of experimental animals during particular critical periods (developmental windows) could help to solve this phenomenon in humans and might facilitate the age-specific prevention of human obesity-related hypertension. In addition, better understanding of particular pathophysiological mechanisms might be useful in so-called personalized medicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chromatin modifications and their function
Kouzarides, T. (2007) · Cell · doi:10.1016/j.cell.2007.02.005 · Cited by 10,883
Epigenetics in human disease and prospects for epigenetic therapy
Egger, G., Liang, G., Aparicio, A., & Jones, P. A. (2004) · Nature · doi:10.1038/nature02625 · Cited by 3,232
Epigenetic Reprogramming in Mammalian Development
Reik, W., Dean, W., & Walter, J. (2001) · Science · doi:10.1126/science.1063443 · Cited by 3,078 · cited 1×
“In the earliest stages of life, the genome undergoes radical changes in epigenetic marks, which are characterized by waves of demethylation of DNA followed by remethylation (Reik et al. 2001).”
BackgroundINFANT MORTALITY, CHILDHOOD NUTRITION, AND ISCHAEMIC HEART DISEASE IN ENGLAND AND WALES
BARKER, D. (1986) · The Lancet · doi:10.1016/s0140-6736(86)91340-1 · Cited by 2,892 · cited 1×
“…distribution of mortality rates from stroke and cardiovascular diseases in 1968–1978 was closely related to the neonatal mortality in 1921–1925, suggesting that poor health and physique of mothers were the important determinants of the risk of stroke in their babies (Barker & Osmond 1986).”
BackgroundPhysiology of Local Renin-Angiotensin Systems
Paul, M., Poyan Mehr, A., & Kreutz, R. (2006) · Physiological Reviews · doi:10.1152/physrev.00036.2005 · Cited by 1,739 · cited 1×
“Apart from the systemic RAS, locally acting RAS has been identified in different organs, including brain, pancreas, kidney, heart, and also adipose tissue (Paul et al. 2006).”
BackgroundFetal and placental size and risk of hypertension in adult life.
Barker, D. J., Bull, A. R., Osmond, C., & Simmonds, S. J. (1990) · BMJ · doi:10.1136/bmj.301.6746.259 · Cited by 1,728
Hyperinsulinemia. A link between hypertension obesity and glucose intolerance.
Modan, M., Halkin, H., Almog, S., Lusky, A., Eshkol, A., Shefi, M., Shitrit, A., & Fuchs, Z. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111776 · Cited by 1,465 · cited 1×
“…demonstrated the association of android (or central) obesity, hypertension, and insulin resistance, which formed the basis for understanding the pathophysiology of obesity-related hypertension (Kissebah et al. 1982, Kalkhoff et al. 1983, Modan et al. 1985, for review see Landsberg et al. (2013)).”
BackgroundGenetics of gene expression and its effect on disease
Emilsson, V., Thorleifsson, G., Zhang, B., Leonardson, A. S., Zink, F., Zhu, J., Carlson, S., Helgason, A., Walters, G. B., Gunnarsdottir, S., et al. (2008) · Nature · doi:10.1038/nature06758 · Cited by 1,296
Kuzawa, C. W., & Sweet, E. (2009) · American Journal of Human Biology · doi:10.1002/ajhb.20822 · Cited by 701
Sympathetic Activation in Obese Normotensive Subjects
Grassi, G., Seravalle, G., Cattaneo, B. M., Bolla, G. B., Lanfranchi, A., Colombo, M., Giannattasio, C., Brunani, A., Cavagnini, F., & Mancia, G. (1995) · Hypertension · doi:10.1161/01.hyp.25.4.560 · Cited by 614 · cited 3×
“High SNA has also been demonstrated in human obesity (Grassi et al. 1995, Vaz et al. 1997, Wofford et al. 2001) in which acute systemic ganglionic blockade lowers BP and peripheral resistance more in normotensive obese subjects than in lean subjects (Shibao et al. 2007).”
BackgroundResultObesity-induced Hypertension: Role of Sympathetic Nervous System, Leptin, and Melanocortins
Hall, J. E., da Silva, A. A., do Carmo, J. M., Dubinion, J., Hamza, S., Munusamy, S., Smith, G., & Stec, D. E. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.r110.113175 · Cited by 528 · cited 4×
“…including hyperinsulinemia, activation of the renin–angiotensin– aldosterone system, SNS stimulation, abnormal levels of certain adipokines such as leptin, and altered spectrum of cytokines acting at the vascular endothelial level (da Silva et al. 2009, Hall et al. 2010, Lambert et al. 2010).”
BackgroundInfluentialLandsberg, L., Aronne, L. J., Beilin, L. J., Burke, V., Igel, L. I., Lloyd‐Jones, D., & Sowers, J. (2013) · The Journal of Clinical Hypertension · doi:10.1111/jch.12049 · Cited by 528
Transgenerational effects of prenatal exposure to the 1944–45 Dutch famine
Veenendaal, M., Painter, R., de Rooij, Sr., Bossuyt, P., van der Post, J., Gluckman, P., Hanson, M., & Roseboom, T. (2013) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.12136 · Cited by 477 · cited 2×
“These imprinting patterns, if not erased after fertilization, may become stable and persist to the next generations of experimental animals (Zambrano et al. 2005, Pinheiro et al. 2008, Torrens et al. 2008) and even of humans (Veenendaal et al. 2013).”
BackgroundEpigenetic programming of the stress response in male and female rats by prenatal restraint stress
Darnaudéry, M., & Maccari, S. (2008) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.11.004 · Cited by 412 · cited 1×
“Besides the role of the prenatal environment, including nutrition, the effects of prenatal stress and social environmental exposures can be important factors (Darnaudéry & Maccari 2008, Kuzawa & Sweet 2009).”
BackgroundRegional Sympathetic Nervous Activity and Oxygen Consumption in Obese Normotensive Human Subjects
Vaz, M., Jennings, G., Turner, A., Cox, H., Lambert, G., & Esler, M. (1997) · Circulation · doi:10.1161/01.cir.96.10.3423 · Cited by 404 · cited 2×
“High SNA has also been demonstrated in human obesity (Grassi et al. 1995, Vaz et al. 1997, Wofford et al. 2001) in which acute systemic ganglionic blockade lowers BP and peripheral resistance more in normotensive obese subjects than in lean subjects (Shibao et al. 2007).”
BackgroundLANDSBERG, L. (1986) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a068066 · Cited by 373 · cited 2×
“This is partially analogous to insulin resistance, which is also selective because high insulin levels elicited by hyperglycemia do not increase glucose uptake in tissues although they stimulate SNA (Landsberg 1986).”
BackgroundRole of Selective Leptin Resistance in Diet-Induced Obesity Hypertension
Rahmouni, K., Morgan, D. A., Morgan, G. M., Mark, A. L., & Haynes, W. G. (2005) · Diabetes · doi:10.2337/diabetes.54.7.2012 · Cited by 319 · cited 4×
“The concept of selective leptin resistance (Mark et al. 1999, 2002, Correia et al. 2002, Rahmouni et al. 2002, 2005a) is based upon the fact that yellow agouti obese mice and diet-induced obese mice were resistant to food intake and body weight effects of systemic leptin administration while…”
BackgroundInfluentialRenal Denervation Attenuates the Sodium Retention and Hypertension Associated With Obesity
Kassab, S., Kato, T., Wilkins, F. C., Chen, R., Hall, J. E., & Granger, J. P. (1995) · Hypertension · doi:10.1161/01.hyp.25.4.893 · Cited by 307 · cited 2×
“Moreover, renal denervation attenuated sodium retention and prevented BP rise in dogs with diet-induced obesity (Kassab et al. 1995).”
BackgroundLow birth weight and hypertension.
Barker, D. J., & Osmond, C. (1988) · BMJ · doi:10.1136/bmj.297.6641.134-b · Cited by 307 · cited 2×
“The hypothesis on the fetal origins of adult diseases in humans was proposed by Barker & Osmond (1988), who suggested that environmental factors, mainly nutrition, can lead to permanent metabolic and structural changes in the fetus and thus can increase the risk of many diseases in adulthood.”
BackgroundChronic Cardiovascular and Renal Actions of Leptin: Role of Adrenergic Activity
Carlyle, M., Jones, O. B., Kuo, J. J., & Hall, J. E. (2002) · Hypertension · doi:10.1161/hy0202.104398 · Cited by 292
Mark, A. L., Shaffer, R. A., Correia, M. L. G., Morgan, D. A., Sigmund, C. D., & Haynes, W. G. (1999) · Journal of Hypertension · doi:10.1097/00004872-199917121-00026 · Cited by 254 · cited 1×
“The concept of selective leptin resistance (Mark et al. 1999, 2002, Correia et al. 2002, Rahmouni et al. 2002, 2005a) is based upon the fact that yellow agouti obese mice and diet-induced obese mice were resistant to food intake and body weight effects of systemic leptin administration while…”
BackgroundOverweight and Hypertension: A 2-Way Street?
Julius, S., Valentini, M., & Palatini, P. (2000) · Hypertension · doi:10.1161/01.hyp.35.3.807 · Cited by 253
Epigenetic modulation of the renal β-adrenergic–WNK4 pathway in salt-sensitive hypertension
Mu, S., Shimosawa, T., Ogura, S., Wang, H., Uetake, Y., Kawakami-Mori, F., Marumo, T., Yatomi, Y., Geller, D. S., Tanaka, H., et al. (2011) · Nature Medicine · doi:10.1038/nm.2337 · Cited by 236
The Concept of Selective Leptin Resistance
Correia, M. L. G., Haynes, W. G., Rahmouni, K., Morgan, D. A., Sivitz, W. I., & Mark, A. L. (2002) · Diabetes · doi:10.2337/diabetes.51.2.439 · Cited by 218 · cited 1×
“The concept of selective leptin resistance (Mark et al. 1999, 2002, Correia et al. 2002, Rahmouni et al. 2002, 2005a) is based upon the fact that yellow agouti obese mice and diet-induced obese mice were resistant to food intake and body weight effects of systemic leptin administration while…”
BackgroundSelective leptin resistance: a new concept in leptin physiology with cardiovascular implications
Mark, A. L., Correia, M. L. G., Rahmouni, K., & Haynes, W. G. (2002) · Journal of Hypertension · doi:10.1097/00004872-200207000-00001 · Cited by 215 · cited 1×
“The concept of selective leptin resistance (Mark et al. 1999, 2002, Correia et al. 2002, Rahmouni et al. 2002, 2005a) is based upon the fact that yellow agouti obese mice and diet-induced obese mice were resistant to food intake and body weight effects of systemic leptin administration while…”
BackgroundMesserli, F. H. (1981) · Archives of Internal Medicine · doi:10.1001/archinte.1981.00340010073016 · Cited by 210 · cited 2×
“Nevertheless, it has been demonstrated (Messerli et al. 1981) that obesity per se raises BP by only a few millimeters of mercury, while 50% of individuals with hypertensive obesity have a much larger rise in BP (Korner 2007).”
BackgroundRole of melanocortin-4 receptors in mediating renal sympathoactivation to leptin and insulin
Rahmouni, K., Haynes, W. G., Morgan, D. A., & Mark, A. L. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-14-05998.2003 · Cited by 185
Antihypertensive effect of α- and β-adrenergic blockade in obese and lean hypertensive subjects
Wofford, M. (2001) · American Journal of Hypertension · doi:10.1016/s0895-7061(01)01293-6 · Cited by 184 · cited 2×
“Similarly, chronic a- and b-adrenergic blockade lowered BP more in obese subjects than in lean hypertensive subjects (Wofford et al. 2001).”
BackgroundSympathetic nervous system behavior in human obesity
Davy, K. P., & Orr, J. S. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.05.024 · Cited by 166
Selective leptin resistance revisited
Mark, A. L. (2013) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00180.2013 · Cited by 162
Prior, L. J., Eikelis, N., Armitage, J. A., Davern, P. J., Burke, S. L., Montani, J.-P., Barzel, B., & Head, G. A. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.141119 · Cited by 157 · cited 1×
“Increased SNA is a characteristic feature of many animal models of obesity (Kassab et al. 1995, Rahmouni et al. 2005a, Prior et al. 2010).”
BackgroundPinheiro, A. R., Salvucci, I. D. M., Aguila, M. B., & Mandarim-de-Lacerda, C. A. (2008) · Clinical Science · doi:10.1042/cs20070302 · Cited by 153 · cited 1×
“These imprinting patterns, if not erased after fertilization, may become stable and persist to the next generations of experimental animals (Zambrano et al. 2005, Pinheiro et al. 2008, Torrens et al. 2008) and even of humans (Veenendaal et al. 2013).”
BackgroundAutonomic Contribution to Blood Pressure and Metabolism in Obesity
Shibao, C., Gamboa, A., Diedrich, A., Ertl, A. C., Chen, K. Y., Byrne, D. W., Farley, G., Paranjape, S. Y., Davis, S. N., & Biaggioni, I. (2007) · Hypertension · doi:10.1161/01.hyp.0000251679.87348.05 · Cited by 147
Systemic and Renal-Specific Sympathoinhibition in Obesity Hypertension
Lohmeier, T. E., Iliescu, R., Liu, B., Henegar, J. R., Maric-Bilkan, C., & Irwin, E. D. (2012) · Hypertension · doi:10.1161/hypertensionaha.111.185074 · Cited by 130
Selective Resistance to Central Neural Administration of Leptin in Agouti Obese Mice
Rahmouni, K., Haynes, W. G., Morgan, D. A., & Mark, A. L. (2002) · Hypertension · doi:10.1161/hy0202.102836 · Cited by 126 · cited 1×
“The concept of selective leptin resistance (Mark et al. 1999, 2002, Correia et al. 2002, Rahmouni et al. 2002, 2005a) is based upon the fact that yellow agouti obese mice and diet-induced obese mice were resistant to food intake and body weight effects of systemic leptin administration while…”
Backgroundda Silva, A. A., Kuo, J. J., & Hall, J. E. (2004) · Hypertension · doi:10.1161/01.hyp.0000128421.23499.b9 · Cited by 117
Chronic hyperinsulinemia and blood pressure. Interaction with catecholamines?
Hall, J. E., Brands, M. W., Kivlighn, S. D., Mizelle, H. L., Hildebrandt, D. A., & Gaillard, C. A. (1990) · Hypertension · doi:10.1161/01.hyp.15.5.519 · Cited by 116
Rapid Onset of Renal Sympathetic Nerve Activation in Rabbits Fed a High-Fat Diet
Armitage, J. A., Burke, S. L., Prior, L. J., Barzel, B., Eikelis, N., Lim, K., & Head, G. A. (2012) · Hypertension · doi:10.1161/hypertensionaha.111.190413 · Cited by 115 · cited 1×
“The enhancement of renal Published by Bioscientifica Ltd. Downloaded from Bioscientifica.com at 11/20/2022 11:31:10AM via free access Jo u rn a l o f E n d o cr in o lo g y SNA due to the impairment of baroreflex function precedes BP rise in rabbits with diet-induced obesity (Armitage et al. 2012).”
Backgroundda Silva, A. A., do Carmo, J. M., Kanyicska, B., Dubinion, J., Brandon, E., & Hall, J. E. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.100636 · Cited by 79
The Brain Melanocortin System, Sympathetic Control, and Obesity Hypertension
da Silva, A. A., do Carmo, J. M., Wang, Z., & Hall, J. E. (2014) · Physiology · doi:10.1152/physiol.00061.2013 · Cited by 47 · cited 1×
“The epigenetic chromatin remodeling is very important because it modifies the accessibility of chromatin to transcription factors, facilitating the recognition of these factors by genes to be expressed and by genes to be silenced, either transiently or permanently (Spotswood & Turner 2002).”
Backgrounddo Carmo, J. M., da Silva, A. A., Rushing, J. S., & Hall, J. E. (2012) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00392.2011 · Cited by 39
Loss of Leptin Actions in Obesity: Two Concepts with Cardiovascular Implications
Mark, A. L., Correia, M. L. G., Rahmouni, K., & Haynes, W. G. (2004) · Clinical and Experimental Hypertension · doi:10.1081/ceh-200031948 · Cited by 32 · cited 1×
“Selective resistance to the metabolic actions of leptin seems to be present in obesity, whereas its action in stimulation of sympathetic tone remains unaltered (Mark et al. 2004).”
Backgrounddo Carmo, J. M., da Silva, A. A., Sessums, P. O., Ebaady, S. H., Pace, B. R., Rushing, J. S., Davis, M. T., & Hall, J. E. (2014) · International Journal of Obesity · doi:10.1038/ijo.2013.177 · Cited by 26 · cited 1×
“One of the most important mechanisms for the induction of sympathoexcitation is the action of leptin on hypothalamic pro-opiomelanocortin (POMC) neurons (Carlyle et al. 2002, da Silva et al. 2004, Tallam et al. 2006, do Carmo et al. 2014).”
Background
Cited by
Metabolic syndrome: pathophysiology, management, and modulation by natural compounds
Rochlani, Y., Pothineni, N. V., Kovelamudi, S., & Mehta, J. L. (2017) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944717711379 · Cited by 1,097
Endothelial Dysfunction and Hypertension
Konukoglu, D., & Uzun, H. (2016) · Advances in Experimental Medicine and Biology · doi:10.1007/5584_2016_90 · Cited by 594
ERICA: prevalences of hypertension and obesity in Brazilian adolescents
Bloch, K. V., Klein, C. H., Szklo, M., Kuschnir, M. C. C., Abreu, G. D. A., Barufaldi, L. A., Veiga, G. V. D., Schaan, B., Silva, T. L. N. D., Moraes, A. J. P., et al. (2016) · Revista de Saúde Pública · doi:10.1590/s01518-8787.2016050006685 · Cited by 266
Anti-diabesity middle eastern medicinal plants and their action mechanisms
Saad, B., Kmail, A., & Haq, S. Z. H. (2022) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2022/2276094 · Cited by 42
Metadata
- Authors
- Vaněčková, I., Maletínská, L., Behuliak, M., Nagelová, V., Zicha, J., & Kuneš, J.
- Venue
- Journal of Endocrinology
- Publisher
- Bioscientifica
- Published
- 2014-12
- Volume
- 223
- Issue
- 3
- Pages
- R63-R78
- ISSN
- 0022-0795 (ISSN-L)
- 1479-6805
- OpenAlex
- W2084171106
- Cited by
- 161
- References
- 43
- FWCI
- 13.06
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.